The initial public offering (IPO) of Anlon Healthcare Limited opened in the Indian primary market on Tuesday and will close on 29 August 2025, leaving investors with just one more day to participate. The issue has so far witnessed a robust subscription across categories, supported by positive grey market cues.
Grey Market Premium (GMP)
According to market observers, Anlon Healthcare shares are trading at a premium of ₹6 in the grey market today. The GMP remains unchanged from Thursday, signaling stable sentiment despite the ongoing volatility in the broader equity market. Analysts say the sustained premium reflects confidence among investors, aided by the strong subscription numbers.
Subscription Status
As of 11:15 AM on Day 3, the IPO was subscribed 4.75 times overall. The retail portion attracted significant demand with bids reaching 32.78 times the reserved quota. The Non-Institutional Investor (NII) category was subscribed 4.72 times, while the Qualified Institutional Buyer (QIB) segment saw a relatively modest 1.01 times subscription.
Expert Views
Market experts are divided in their recommendations.
- Sachin Jasuja, Head of Equities and Founding Partner at Centricity WealthTech, believes the company stands to benefit from government initiatives such as ‘Make in India’ and the Production Linked Incentive (PLI) scheme, which are driving investments in Active Pharmaceutical Ingredient (API) manufacturing. He expects policy support to aid growth and margin stability for players like Anlon Healthcare.
- Shivani Nyati, Head of Wealth at Swastika Investmart, acknowledged the company’s positioning as the first producer of Loxoprofen and related formulations but cautioned that operations remain heavily dependent on a single facility in Rajkot, Gujarat. She added that while the business fundamentals are sound, the IPO valuation appears fully priced.
Key Dates
- IPO Closes: 29 August 2025
- Allotment Date (Likely): 30 August 2025 (or 1 September in case of a weekend delay)
- Listing Date (Likely): 3 September 2025
The company, which specializes in producing and marketing APIs aligned with global standards, is drawing strong retail participation even as broader markets remain under pressure.
